IAIna Selseth Almdahl

Ina Selseth Almdahl

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ina Selseth Almdahl has a total of 144 co-authors. Here are the top co-authors by number of shared publications:

  • Tormod Fladby

    Department of Neurology, Akershus University Hospital, Lørenskog, Norway

    8 shared publications
  • Ingvild Saltvedt

    Department of Neuromedicine and Movement Science, NTNU, Norwegian University of Science and Technology, Trondheim, Norway

    6 shared publications
  • Sigrid B. Sando

    Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway

    6 shared publications
  • Aree Witoelar

    NORMENT, K.G. Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway

    5 shared publications
  • Eystein Stordal

    Department of Psychiatry, Namsos Hospital, Namsos, Norway

    5 shared publications
  • Geir Bråthen

    Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway

    5 shared publications

Latest Publications

  • Open Access

    Quality of Life, Mental Health and Executive Function in Individuals with Basal Cell Naevus Syndrome

    by Karianne H. Brandtzæg, Charlotte Von der Lippe, Ina S. Almdahl, Anvor Rossow, Ragnhild S. Falk, Petter Gjersvik, Kristin H. Hortemo, Solrun Sigurdardottir

    Basal cell naevus syndrome (BCNS) is a rare genetic disorder characteriszed by multiple basal cell carcinomas, as well as different extracutaneous tumours, cysts and abnormalities. Research on health-related quality of life (HRQoL) and mental health in BCNS is limited. This cross-sectional study included 62 individuals ≥18 years diagnosed with BCNS. Clinical and genetic data were collected, and five5 validated questionnaires were used to assess self-reported HRQoL, psychological distress, fatigue, pain and everyday executive functioning. Median regression analyses were conducted to identify factors associated with HRQoL. Independent samples t-tests and one proportion z-tests were conducted to compare the BCNS group with the general population. Individuals with BCNS reported lower HRQoL compared with the general population. Elevated anxiety symptoms were observed in 14 individuals (24%). The proportion of individuals reporting everyday executive deficits was higher in the BCNS group compared with the general population. Engagement in employment or higher education was associated with better physical and mental HRQoL, whereas symptoms of anxiety and everyday executive deficits were associated with reduced mental HRQoL. Findings highlight mental health challenges in BCNS. Routine screening for anxiety and executive functioning is suggested as essential steps in identifying those at risk and provideproviding timely psychological support.

  • Open Access

    Task-based functional connectivity reveals aberrance with the salience network during emotional interference in late-life depression

    by Ina S. Almdahl, Liva J. Martinussen, Olga Therese Ousdal, Miroslawa Kraus, Piotr Sowa, Ingrid Agartz, Maria S. Korsnes

    Late-life depression (LLD) is a common and debilitating disorder. Previously, resting-state studies have revealed abnormal functional connectivity (FC) of brain networks in LLD. Since LLD is associ...


  • Open Access

    Brain Morphometric Correlates of Depressive Symptoms among Patients with and without Dementia

    by Maria Lage Barca, Dag Alnæs, Knut Engedal, Karin Persson, Rannveig Sakshaug Eldholm, Nikias Siafarikas, Ina Selseth Almdahl, Maria Stylianou-Korsnes, Ingvild Saltvedt, Geir Selbæk, et al.

    Introduction: Findings regarding brain morphometry among patients with dementia and concomitant depressive symptoms have been inconsistent. Thus, the aim of the present study was to test the hypothesis that dementia and concomitant depressive symptoms are associated with structural brain changes in the temporal lobe measured with structural magnetic resonance imaging (MRI). Methods: A sample of 492 patients from Norwegian memory clinics (n = 363) and Old Age Psychiatry services (n = 129) was studied. The assessment included the Cornell Scale for Depression in Dementia (CSDD), Instrumental Activities of Daily Living Scale, Mini Mental State Examination, and MRI of the brain, processed with FreeSurfer to derive ROI measures of cortical thickness, volume, and area using the Desikan-Killiany parcellation, as well as subcortical volumes. Dementia was diagnosed according to ICD-10 research criteria. Correlates of brain morphometry using multiple linear regression were examined. Results: Higher scores on the CSDD were associated with larger cortical volume (β = 0.125; p value = 0.003) and area of the left isthmus of the cingulate gyrus (β = 0.151; p value = <0.001) across all patients. Inclusion of an interaction term (dementia × CSDD) revealed a smaller area in the left temporal pole (β = −0.345; p value = 0.001) and right-transverse temporal cortex (β = −0.321; p value = 0.001) in patients with dementia and depressive symptoms. Discussion/Conclusion: We confirm the previous findings of structural brain changes in temporal regions among patients with dementia and concomitant depressive symptoms. This may contribute to a better understanding of the mechanisms underlying depression in dementia. To the best of our knowledge, this is the largest study conducted on this topic to date.


  • Brain pathology and cognitive scores prior to onset of late‐life depression

    by Ina S. Almdahl, Ingrid Agartz, Kenneth Hugdahl, Maria S. Korsnes, For The Alzheimer’s Disease Neuroimaging Initiative

    Objectives: Understanding the biological changes that occur prior to onset of late‐life depression (LLD) is key to its prevention. To investigate potential predictors of LLD, we assessed cognitive scores and neurodegenerative and vascular biomarkers in healthy older adults who later developed depression.Methods: Longitudinal data from the Alzheimer's Disease Neuroimaging Initiative of 241 cognitively unimpaired and non‐depressed older adults aged 56–90 at baseline with at least 4 years of follow‐up were included. Participants were classified based on whether they developed an incident depression (n = 96) or not (n = 145). Cognitive measures of memory, executive functioning, and language, and biomarkers proposed to be related to LLD: hippocampal volume, white matter hyperintensity volume (WMH), and cortical and cerebrospinal fluid (CSF) amyloid beta levels, were compared between the incident depression and the never‐depressed groups at four time points: at baseline, the visit prior to onset, at onset, and after the onset of depression.Results: In the incident depression group, there was a mild decline in cognitive scores from baseline to the visit before depression onset compared with the never‐depressed group. The cognitive differences between the groups became more marked after depression onset. Baseline cortical amyloid burden, CSF amyloid beta levels, and WMH were significant predictors of incident depression. Compared to the non‐depressed group, hippocampal volume was not reduced before onset, but was reduced following depression.Conclusions: Amyloid pathology and WMH can predict future development of LLD in cognitively unimpaired individuals and may be involved in precipitating vulnerability for depression in older adults.


  • Open Access

    Inhibition of emotions in healthy aging: age‐related differences in brain network connectivity

    by Ina S. Almdahl, Liva J. Martinussen, Ingrid Agartz, Kenneth Hugdahl, Maria S. Korsnes

    Introduction: Successful inhibition of distracting emotions is important for preserving well‐being and daily functioning. There is conflicting evidence regarding the impact of healthy aging on emotional inhibition, and possible age‐related alterations in the neuronal underpinnings of emotional interference processing are unexplored.Methods: Thirty younger (mean age 26 years; 15 women) and 30 older (mean age 71 years; 13 women) healthy adults performed a face–word emotional Stroop task while undergoing functional magnetic resonance imaging of the brain. A resting‐state scan was acquired for calculating the amplitude of low‐frequency fluctuations as an estimate of vascular reactivity. Comparisons of brain activation during the task were assessed in a whole‐brain, voxel‐wise analysis, contrasting congruent, and incongruent conditions. The canonical regions of the frontoparietal, salience, dorsal attention, and default mode networks were used as seed regions for assessing functional connectivity within and between large‐scale brain networks. Task performance was evaluated using response accuracy and response time.Results: The older adults had longer response times and lower task accuracy than the younger adults, but the emotional interference effect was not significantly different between the groups. Whole‐brain analysis revealed no significant age‐related differences in brain activation patterns. Rescaling the data for estimated variability in vascular reactivity did not affect the results. In older adults, there was relatively stronger functional connectivity with the default mode network, the sensorimotor network, and the dorsal attention network for the frontoparietal and salience network seeds during the task. Conversely, younger adults had relatively stronger connections within and between the frontoparietal and salience networks.Conclusion: In this first fMRI study of emotional Stroop interference in older and younger adults, we found that the emotional interference effect was unchanged in healthy aging and replicated the finding from non‐emotional task studies that older adults have greater between‐network and less within‐network connectivity compared to younger adults.


  • Author Correction: Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

    by Iris E. Jansen, Jeanne E. Savage, Kyoko Watanabe, Julien Bryois, Dylan M. Williams, Stacy Steinberg, Julia Sealock, Ida K. Karlsson, Sara Hägg, Lavinia Athanasiu, et al.

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  • Open Access

    Author Correction: GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

    by Arvid Rongve, Aree Witoelar, Agustín Ruiz, Lavinia Athanasiu, Carla Abdelnour, Jordi Clarimon, Stefanie Heilmann-Heimbach, Isabel Hernández, Sonia Moreno-Grau, Itziar de Rojas, et al.

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  • Open Access

    The effect of anxiety on cognition in older adult inpatients with depression: results from a multicenter observational study

    by Liva Jenny Martinussen, Jūratė Šaltytė Benth, Ina Selseth Almdahl, Tom Borza, Geir Selbæk, Bodil Mcpherson, Maria Stylianou Korsnes


  • Open Access

    GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

    by Arvid Rongve, Aree Witoelar, Agustín Ruiz, Lavinia Athanasiu, Carla Abdelnour, Jordi Clarimon, Stefanie Heilmann-Heimbach, Isabel Hernández, Sonia Moreno-Grau, Itziar de Rojas, et al.

    Dementia with Lewy Bodies (DLB) is a common neurodegenerative disorder with poor prognosis and mainly unknown pathophysiology. Heritability estimates exceed 30% but few genetic risk variants have been identified. Here we investigated common genetic variants associated with DLB in a large European multisite sample. We performed a genome wide association study in Norwegian and European cohorts of 720 DLB cases and 6490 controls and included 19 top-associated single-nucleotide polymorphisms in an additional cohort of 108 DLB cases and 75545 controls from Iceland. Overall the study included 828 DLB cases and 82035 controls. Variants in the ASH1L/GBA (Chr1q22) and APOE ε4 (Chr19) loci were associated with DLB surpassing the genome-wide significance threshold (p < 5 × 10−8). One additional genetic locus previously linked to psychosis in Alzheimer’s disease, ZFPM1 (Chr16q24.2), showed suggestive association with DLB at p-value < 1 × 10−6. We report two susceptibility loci for DLB at genome-wide significance, providing insight into etiological factors. These findings highlight the complex relationship between the genetic architecture of DLB and other neurodegenerative disorders.


  • Top Cited Papers

    Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

    by Iris E. Jansen, Jeanne E. Savage, Kyoko Watanabe, Julien Bryois, Dylan M. Williams, Stacy Steinberg, Julia Sealock, Ida K. Karlsson, Sara Hägg, Lavinia Athanasiu, et al.

    Alzheimer’s disease (AD) is highly heritable and recent studies have identified over 20 disease-associated genomic loci. Yet these only explain a small proportion of the genetic variance, indicating that undiscovered loci remain. Here, we performed a large genome-wide association study of clinically diagnosed AD and AD-by-proxy (71,880 cases, 383,378 controls). AD-by-proxy, based on parental diagnoses, showed strong genetic correlation with AD (rg = 0.81). Meta-analysis identified 29 risk loci, implicating 215 potential causative genes. Associated genes are strongly expressed in immune-related tissues and cell types (spleen, liver, and microglia). Gene-set analyses indicate biological mechanisms involved in lipid-related processes and degradation of amyloid precursor proteins. We show strong genetic correlations with multiple health-related outcomes, and Mendelian randomization results suggest a protective effect of cognitive ability on AD risk. These results are a step forward in identifying the genetic factors that contribute to AD risk and add novel insights into the neurobiology of AD.